3. Merial - Top 10 animal health companies

2013 Revenue: $2.73 billion
HQ: Lyon, France

Sanofi ($SNY) has struggled a bit with Merial since its joint venture with Merck ($MRK) was interrupted by Merck's merger with Schering-Plough in 2011 and regulatory concerns prevented them from hooking back up afterward. Sales last year were down 5.3% as the company faced heavy competition to its flea and tick product Frontline. Sales of companion animal products, which make up 60% of its total, fell 9.8%. It did get approval in the U.S. last year for its new chewable flea and tick treatment in dogs, NexGard. Its much smaller production animal category was up 2.1% to €790 million ($1.1 billion). It was helped some by its late 2012 acquisition of India's Dosch Pharmaceuticals Private, picking up 86 drugs and a sales force of 279 people in one of the world's largest and fastest-growing animal health markets. It said it expected the unit to add about €350 million ($464 million) from that acquisition. -- Eric Palmer (email | Twitter)

For more: 
Sanofi animal health deal puts it in India
Sanofi eyes cost cuts and deals for vet unit

3. Merial - Top 10 animal health companies

Suggested Articles

Pfizer spinoff Zoetis met Q2 expectations and brightened its full-year forecast, but it's looking to M&A to drive further growth.

Fresenius’ new CEO has pulled off a dealmaking double play, committing more than $5.4 billion to expand its reach in both sterile generics and in biosimilars.

Bayer’s pharma products have been growing lickety-split, and its 2016 numbers show just how—and how much. But with the big Monsanto merger top of mind at Bayer…